Cap on cancer drug margins must reach patients, says ex-NHA chief Indu Bhushan

The NPPA's move to cap trade margins on 137 anti-cancer medicines is an important step, but its success depends on savings reaching patients, former National Health Authority CEO Indu Bhushan told The Hindu. The revised prices take effect from November 9. He said affordable cancer care also needs pooled procurement, strategic purchasing and public investment.